Development and Validation of an Analytical Method for Quantitation of Bisphenol S in Rodent Plasma, Amniotic Fluid and Fetuses by UPLC-MS-MS

被引:1
|
作者
Silinski, Melanie A. Rehder [1 ]
Fletcher, Brenda L. [1 ]
Fernando, Reshan A. [1 ]
Robinson, Veronica G. [2 ]
Waidyanatha, Suramya [2 ]
机构
[1] RTI Int, Discovery Sci Unit, POB 12194, Res Triangle Pk, NC 27709 USA
[2] NIEHS, Div Natl Toxicol Program, POB 12233, Res Triangle Pk, NC 27709 USA
基金
美国国家卫生研究院;
关键词
TANDEM MASS-SPECTROMETRY; UNITED-STATES; URINE; EXPOSURE; ANALOGS; QUANTIFICATION; APPLICABILITY; SERUM; RATS;
D O I
10.1093/jat/bkab008
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Bisphenol S (BPS) has been detected in personal care products, water, food and indoor house dust, demonstrating the potential for human exposure. Due to limited data to characterize the hazard of BPS, the National Toxicology Program (NTP) is investigating the toxicity of BPS in rodent models. Generating systemic exposure data is integral to putting toxicological findings into context. The objective of this work was to develop and validate a method to quantitate free (unconjugated parent) and total (free and all conjugated forms of) BPS in rodent plasma, amniotic fluid and fetal homogenate in support of NTP studies. The method used incubation with (total BPS) and without (free BPS) deconjugating enzyme and then protein precipitation followed by ultra-performance liquid chromatography-tandem mass spectrometry. In Sprague Dawley rat plasma, the method was linear (r >= 0.99) over the range 5-1,000 ng/mL, accurate (mean relative error (RE) <= +/- 10.5%) and precise (relative standard deviation (RSD) <= 7.7%). Mean recoveries were >= 93.1% for both free and total analyses. The limits of detection were 1.15 ng/mL (free) and 0.862 ng/mL (total) in plasma. The method was evaluated in the following study matrices: (i) male Hsd:Sprague Dawley (R) SD (R) (HSD) rat plasma, (ii) female HSD rat plasma, (iii) male B6C3F1 mouse plasma, (iv) female B6C3F1 mouse plasma, (v) HSD rat gestational day (GD) 18 dam plasma, (vi) HSD rat GD 18 amniotic fluid, (vii) HSD rat GD 18 fetal homogenate and (viii) HSD rat postnatal day 4 pup plasma (mean %RE <= +/- 8.2 and %RSD <= 8.7). Stability of BPS in extracted samples was demonstrated for up to 7 days at various temperatures, and freeze-thaw stability was demonstrated after three cycles over 7 days. BPS in various matrices stored at -80 degrees C for at least 60 days was within 92.1-115% of Day 0 concentrations, demonstrating its stability in these matrices. These data demonstrate that this simple method is suitable for determination of free and total BPS in plasma, amniotic fluid and fetuses following exposure of rodents to BPS.
引用
收藏
页码:277 / 284
页数:8
相关论文
共 50 条
  • [21] Development of a UPLC-MS-MS Method for Quantitative Determination of BYYT-25 in Rat Plasma and Its Application to a Pharmacokinetic Study
    Meng, Minxin
    Yu, Lushan
    Yao, Tongwei
    Sheng, Rong
    Hu, Yongzhou
    Zeng, Su
    JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2011, 49 (03) : 255 - 258
  • [22] Development and validation of analytical method for Naftopidil in human plasma by LC-MS/MS
    Jain, Pritam S.
    Bobade, Kajal D.
    Bari, Pankaj R.
    Girase, Devendra S.
    Surana, Sanjay J.
    ARABIAN JOURNAL OF CHEMISTRY, 2015, 8 (05) : 648 - 654
  • [23] Development and Interlaboratory Validation of Two Fast UPLC-MS-MS Methods Determining Urinary Bisphenols, Parabens and Phthalates
    Van der Meer, Thomas P.
    van Faassen, Martijn
    Frederiksen, Hanne
    van Beek, Andre P.
    Wolffenbuttel, Bruce H. R.
    Kema, Ido P.
    van Vliet-Ostaptchouk, Jana V.
    JOURNAL OF ANALYTICAL TOXICOLOGY, 2019, 43 (06) : 452 - 464
  • [24] Development, validation, and application of an UPLC-MS/MS method for norvancomycin analysis in human blood plasma
    Mei, Shenghui
    Wang, Jiaqing
    Cheng, Qing
    Zhu, Leting
    Yang, Li
    Chen, Ruiling
    Zhao, Zhigang
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2018, 1072 : 199 - 204
  • [25] Development and validation of a UPLC-MS/MS method for quantification of doxofylline and its metabolites in human plasma
    Fang, Li-Na
    Mao, Ming-Qing
    Zhao, Xiao-Hua
    Yang, Ling
    Jia, Hui
    Xia, Shu-Yue
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2019, 174 : 220 - 225
  • [26] Development and validation of a highly sensitive UPLC-MS/MS method for the determination of Huperzine A in rat plasma
    Zhang, Kejun
    Wang, Haizhou
    BIOMEDICAL CHROMATOGRAPHY, 2024, 38 (11)
  • [27] Development and validation of the quantitative determination of avapritinib in rat plasma by a bioanalytical method of UPLC-MS/MS
    Xu, Xuegu
    Luo, Shunbin
    Yang, Qiang
    Wang, Yingjie
    Li, Wenlong
    Lin, Guanyang
    Xu, Ren-ai
    ARABIAN JOURNAL OF CHEMISTRY, 2021, 14 (06)
  • [28] Development and Validation of a Bioanalytical Method to Determine Empagliflozin in Human Plasma Using UPLC-MS/MS
    Sumithra, Mani
    Andrew, David John
    Aanandhi, Muthukumar Vijey
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2024, 58 (01) : S325 - S331
  • [29] DEVELOPMENT AND VALIDATION OF SENSITIVE UPLC-MS/MS BASED METHOD FOR THE ESTIMATION OF CRIZOTINIB IN HUMAN PLASMA
    Wani, T. A.
    Iqbal, M.
    Darwish, I. A.
    Khalil, N. Y.
    Zargar, S.
    DIGEST JOURNAL OF NANOMATERIALS AND BIOSTRUCTURES, 2014, 9 (02) : 693 - 704
  • [30] Validation of UPLC-MS/MS Method for the Determination of Cefprozil in Human Plasma
    Gan, Dongmei
    Xia, Kejun
    Shan, Shuqin
    Yu, Yue
    Shi, Xiaojun
    LATIN AMERICAN JOURNAL OF PHARMACY, 2016, 35 (02): : 254 - 258